RalphASchutzMD

Clinical Trials

• Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously Start of enrollment: 2007 Jan 01

  Completed

  Phase 1

• A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly Start of enrollment: 2007 Dec 01

  Completed

  Phase 1

• First Time in Human Study of Protexia Start of enrollment: 2008 Sep 01

  Completed

  Phase 1

• VA106483 Dose Response Study in Elderly Males Start of enrollment: 2009 Jun 01

  Completed

  Phase 1

• Ph1 Study of Valortim and Ciprofloxacin in Humans Start of enrollment: 2009 Aug 01

  Suspended

  Phase 1

• A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days Start of enrollment: 2010 Feb 01

  Completed

  Phase 1

• A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers Start of enrollment: 2010 May 01

  Completed

  Phase 1

• Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects Start of enrollment: 2010 Jun 01

  Terminated

  Phase 1

• VA106483 Dose Response in Females Start of enrollment: 2010 Jul 01

  Completed

  Phase 1

• Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Start of enrollment: 2010 Aug 01

  Completed

  Phase 1

• Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects Start of enrollment: 2010 Dec 01

  Completed

  Phase 1

• Study in Healthy Males to Assess Distribution, Metabolism, and Excretion of Radio-labelled AZD9742 Administered as a 2-hour Infusion Start of enrollment: 2011 Jan 01

  Withdrawn

  Phase 1

• Join now to see all